Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients receiving efzofitimod vs. placebo were steroid-free with a stable/improved King ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued Primary Endpoint Details: ...

Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT™ study and determine ...

A new study published in the journal of Chest Pulmonary showed that nephrolithiasis is more common in Black women in the ...

A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny ...

Please provide your email address to receive an email when new articles are posted on . A blood test was able to tell sarcoidosis apart from tuberculosis and lung cancer. Researchers said this method ...

Sarcoidosis is a rare inflammatory condition that develops when groups of cells in your immune system form patches of swollen tissue, called granulomas. These can cluster in the organs of the body, ...

Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Relationship between basal thinning of the ...

NORTH PLAINFIELD, N.J. (WPVI) -- The immune system helps protect us against disease, but sometimes, it becomes the source of trouble. That's the case with sarcoidosis. "I apparently had it since I was ...